Conmed Corp (CNMD)
71.25
+0.50
(+0.71%)
USD |
NYSE |
May 07, 09:41
Conmed Cash from Investing (Quarterly): -2.035M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.035M |
| December 31, 2023 | -4.855M |
| September 30, 2023 | -5.394M |
| June 30, 2023 | -5.529M |
| March 31, 2023 | -4.254M |
| December 31, 2022 | -6.318M |
| September 30, 2022 | -91.26M |
| June 30, 2022 | -148.27M |
| March 31, 2022 | -3.687M |
| December 31, 2021 | -3.188M |
| September 30, 2021 | -5.575M |
| June 30, 2021 | -2.994M |
| March 31, 2021 | -3.109M |
| December 31, 2020 | -3.149M |
| September 30, 2020 | -0.06M |
| June 30, 2020 | -3.752M |
| March 31, 2020 | -6.677M |
| December 31, 2019 | -8.859M |
| September 30, 2019 | -4.869M |
| June 30, 2019 | -4.984M |
| March 31, 2019 | -368.95M |
| December 31, 2018 | -4.756M |
| September 30, 2018 | -4.46M |
| June 30, 2018 | -3.508M |
| March 31, 2018 | -3.783M |
| Date | Value |
|---|---|
| December 31, 2017 | -4.628M |
| September 30, 2017 | -17.14M |
| June 30, 2017 | -4.706M |
| March 31, 2017 | -2.584M |
| December 31, 2016 | -4.317M |
| September 30, 2016 | 2.409M |
| June 30, 2016 | -4.904M |
| March 31, 2016 | -259.21M |
| December 31, 2015 | -6.78M |
| September 30, 2015 | -3.695M |
| June 30, 2015 | -8.973M |
| March 31, 2015 | -4.914M |
| December 31, 2014 | -7.181M |
| September 30, 2014 | -4.854M |
| June 30, 2014 | -4.576M |
| March 31, 2014 | -4.065M |
| December 31, 2013 | -4.893M |
| September 30, 2013 | -5.351M |
| June 30, 2013 | -4.071M |
| March 31, 2013 | -4.13M |
| December 31, 2012 | -7.137M |
| September 30, 2012 | -23.10M |
| June 30, 2012 | -5.172M |
| March 31, 2012 | -70.54M |
| December 31, 2011 | -8.999M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-148.27M
Minimum
Jun 2022
-0.06M
Maximum
Sep 2020
-15.94M
Average
-4.862M
Median
Cash from Investing (Quarterly) Benchmarks
| Inspire Medical Systems Inc | -151.72M |
| SI-BONE Inc | -18.91M |
| Inari Medical Inc | 39.16M |
| Electromed Inc | -0.087M |
| Myomo Inc | 2.294M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 29.12M |
| Cash from Financing (Quarterly) | -17.01M |
| Free Cash Flow | 141.50M |
| Free Cash Flow Per Share (Quarterly) | 0.8661 |
| Free Cash Flow to Equity (Quarterly) | 10.13M |
| Free Cash Flow to Firm (Quarterly) | 34.52M |
| Free Cash Flow Yield | 6.29% |